N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence
Authors
Keywords
-
Journal
Journal of Inflammation Research
Volume Volume 14, Issue -, Pages 2993-3013
Publisher
Informa UK Limited
Online
2021-07-06
DOI
10.2147/jir.s306849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- N-acetylcysteine (NAC) and Hydrogen Sulfide (H2S) in Coronavirus Disease 2019 (COVID-19)
- (2021) Arno R. Bourgonje et al. ANTIOXIDANTS & REDOX SIGNALING
- Chitin‐lipid interactions and the potential relationship between Demodex and SARS‐CoV ‐2
- (2021) Alin Laurentiu Tatu et al. Dermatologic Therapy
- Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
- (2021) Eduardo López-Medina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup
- (2021) Eric J. Rubin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
- (2021) Paul A Goepfert et al. LANCET INFECTIOUS DISEASES
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
- (2021) Federico Angriman et al. Lancet Respiratory Medicine
- Interleukin-6: obstacles to targeting a complex cytokine in critical illness
- (2021) Oliver J McElvaney et al. Lancet Respiratory Medicine
- SARS-CoV-2 evolution and vaccines: cause for concern?
- (2021) Thomas C Williams et al. Lancet Respiratory Medicine
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Responding to Covid-19 — A Once-in-a-Century Pandemic?
- (2020) Bill Gates NEW ENGLAND JOURNAL OF MEDICINE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus
- (2020) Mark F. McCarty et al. PROGRESS IN CARDIOVASCULAR DISEASES
- COVID-19 and its implications for thrombosis and anticoagulation
- (2020) Jean Marie Connors et al. BLOOD
- Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
- (2020) Concepción Peiró et al. CIRCULATION
- N-Acetylcysteine: a potential therapeutic agent for SARS-CoV-2
- (2020) Francis L. Poe et al. MEDICAL HYPOTHESES
- Mild or Moderate Covid-19
- (2020) Rajesh T. Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- and Animal Models for SARS-CoV-2 research
- (2020) Kazuo Takayama TRENDS IN PHARMACOLOGICAL SCIENCES
- Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
- (2020) Peter M George et al. Lancet Respiratory Medicine
- N-Acetyl-Cysteine Regenerates Albumin Cys34 by a Thiol-Disulfide Breaking Mechanism: An Explanation of Its Extracellular Antioxidant Activity
- (2020) Alessandra Altomare et al. Antioxidants
- SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
- (2020) Firas A. Rabi et al. Pathogens
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
- (2020) Ahmed O. Hassan et al. CELL
- Disseminated Intravascular Coagulation: A Devastating Systemic Disorder of Special Concern with COVID ‐19
- (2020) Parmvir Singh et al. Dermatologic Therapy
- N-acetylcysteine as a potential treatment for novel coronavirus disease 2019
- (2020) Rangel-Méndez Jorge-Aarón et al. Future Microbiology
- Lessons for COVID-19 Immunity from Other Coronavirus Infections
- (2020) Alan Sariol et al. IMMUNITY
- Covid-19 — Implications for the Health Care System
- (2020) David Blumenthal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- Directly Acting Antivirals for COVID-19: Where Do We Stand?
- (2020) Siew L. Teoh et al. Frontiers in Microbiology
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
- (2020) Naomi Holman et al. Lancet Diabetes & Endocrinology
- Coagulation abnormalities and thrombosis in patients with COVID-19
- (2020) Marcel Levi et al. Lancet Haematology
- COVID-19 and Diabetes: The Importance of Controlling RAGE
- (2020) Ernestina M. De Francesco et al. Frontiers in Endocrinology
- N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease
- (2020) Leah Mursaleen et al. Antioxidants
- Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
- (2020) Artur Słomka et al. Pathogens
- SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings
- (2020) Rajkumar Singh Kalra et al. Pathogens
- Impact of Thiol–Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor
- (2020) Sanchita Hati et al. ACS Omega
- Accelerated preclinical paths to support rapid development of COVID-19 therapeutics
- (2020) Jay A. Grobler et al. Cell Host & Microbe
- ACTIVating Resources for the COVID-19 Pandemic: In vivo Models for Vaccines and Therapeutics
- (2020) Judith A. Hewitt et al. Cell Host & Microbe
- Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine
- (2020) Homam Ibrahim et al. CLINICAL IMMUNOLOGY
- Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19
- (2020) Julio Cesar Garcia de Alencar et al. CLINICAL INFECTIOUS DISEASES
- Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19
- (2020) Yan Liu et al. MEDICINE
- The Impact of COVID-19 Disease on Platelets and Coagulation
- (2020) Geoffrey D. Wool et al. PATHOBIOLOGY
- D-dimer level in COVID-19 infection: a systematic review
- (2020) Mehrdad Rostami et al. Expert Review of Hematology
- ACEIs and ARBs and Their Correlation with COVID-19: A Review
- (2020) Awgichew Shewasinad Yehualashet et al. Infection and Drug Resistance
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergence of a Highly Fit SARS-CoV-2 Variant
- (2020) Ralph S. Baric NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
- (2020) Ralf Kircheis et al. Frontiers in Immunology
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- Two-bag intravenous N-acetylcysteine, antihistamine pretreatment and high plasma paracetamol levels are associated with a lower incidence of anaphylactoid reactions to N-acetylcysteine
- (2019) Alaa Daoud et al. CLINICAL TOXICOLOGY
- N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why
- (2018) Giancarlo Aldini et al. FREE RADICAL RESEARCH
- Angioedema
- (2018) James A. Tarbox et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity
- (2018) Dongjoo Kim et al. Scientific Reports
- Nano based drug delivery systems: recent developments and future prospects
- (2018) Jayanta Kumar Patra et al. JOURNAL OF NANOBIOTECHNOLOGY
- N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia
- (2018) Qianwen Zhang et al. MEDICINE
- Glutathione Primes T Cell Metabolism for Inflammation
- (2017) Tak W. Mak et al. IMMUNITY
- Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
- (2017) Suzan Wetzels et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Endosymbiosis and its significance in dermatology
- (2017) K. Kubiak et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea
- (2017) M. Schaller et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Recurrent Acute Rhinosinusitis: A Single Blind Clinical Study of N-Acetylcysteine vs Ambroxol Associated to Corticosteroid Therapy
- (2017) A. Macchi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Effect of high N-acetylcysteine concentrations on antibiotic activity against a large collection of respiratory pathogens
- (2016) Giulia Landini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- N -Acetyl-L-cysteine and Cysteamine: New Strategies Against Mixed Biofilms of Non-encapsulated Streptococcus pneumoniae and Non-typeable Haemophilus influenzae
- (2016) Mirian Domenech et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- N-acetylcysteine-loaded PLGA nanoparticles outperform conventional N-acetylcysteine in acute lung injuries in vivo
- (2016) Ali Akbar Karimi Zarchi et al. International Journal of Polymeric Materials and Polymeric Biomaterials
- The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections
- (2016) Francesco Blasi et al. RESPIRATORY MEDICINE
- N-acetylcysteine-loaded PLGA nanoparticles outperform conventional N-acetylcysteine in acute lung injuries in vivo
- (2016) Ali Akbar Karimi Zarchi et al. International Journal of Polymeric Materials and Polymeric Biomaterials
- N-Acetylcysteine Selectively Antagonizes the Activity of Imipenem in Pseudomonas aeruginosa by an OprD-Mediated Mechanism
- (2015) Jerónimo Rodríguez-Beltrán et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of N-Acetylcysteine on Wound Healing of Nasal Mucosa
- (2015) Beyhan Yilmaz et al. JOURNAL OF CRANIOFACIAL SURGERY
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- N-acetyl-l-cystine (NAC) protects against H9N2 swine influenza virus-induced acute lung injury
- (2014) Rui-Hua Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
- (2014) Mukta Paranjpe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Proteomics study ofN-acetylcysteine response in H1N1-infected cells by using mass spectrometry
- (2014) Hanzhi Wu et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- High-Dose N-Acetylcysteine Therapy for Novel H1N1 Influenza Pneumonia
- (2013) Kang Yiu Lai ANNALS OF INTERNAL MEDICINE
- The chemistry and biological activities of N-acetylcysteine
- (2013) Yuval Samuni et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial
- (2013) D Nicholas Bateman et al. LANCET
- N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial
- (2012) Zhi-Wei Lai et al. ARTHRITIS AND RHEUMATISM
- PLGA-based nanoparticles: An overview of biomedical applications
- (2012) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Respiratory Syncytial Virus Inhibits Ciliagenesis in Differentiated Normal Human Bronchial Epithelial Cells: Effectiveness of N-Acetylcysteine
- (2012) Manuel Mata et al. PLoS One
- N-acetyl-l-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)
- (2011) Manuel Mata et al. BIOCHEMICAL PHARMACOLOGY
- Neutrophil Elastase Contributes to Acute Lung Injury Induced by Bilateral Nephrectomy
- (2010) Tomoko Ishii et al. AMERICAN JOURNAL OF PATHOLOGY
- N-Acetylcysteine-Mediated Modulation of Bacterial Antibiotic Susceptibility
- (2010) M. Goswami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells
- (2010) S. Sharmeen et al. BLOOD
- Role of oxidative stress on diesel-enhanced influenza infection in mice
- (2010) Kymberly M Gowdy et al. Particle and Fibre Toxicology
- N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus
- (2009) Janina Geiler et al. BIOCHEMICAL PHARMACOLOGY
- Topical N-acetyl cysteine (NAC) Reduces Late Phase Nasal Symptoms Following Ragweed Challenge
- (2009) C.J. Lane et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Role ofN-acetylcysteine and cystine in glutathione synthesis in human erythrocytes
- (2009) Stephney Whillier et al. REDOX REPORT
- Nanoparticle formulations in pulmonary drug delivery
- (2008) Mark M. Bailey et al. MEDICINAL RESEARCH REVIEWS
- N-Acetylcysteine in the Prevention of Contrast-Induced Nephropathy
- (2007) S. Fishbane Clinical Journal of the American Society of Nephrology
- Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning
- (2003) L. E. Schmidt et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started